Temple University Health System’s preparations for and treatment of patients amidst the coronavirus pandemic continue to be part of the media’s COVID-19 coverage.
- Dr. Moncef Slaoui, Chief Advisor to Operation Warp Speed, was at Temple University Hospital (TUH) on Friday, November 20, to discuss Temple’s participation in the Phase 3 clinical research study known as the ENSEMBLE trial to evaluate the safety and efficacy of an investigational COVID-19 vaccine made by Janssen Pharmaceutical Companies of Johnson & Johnson. Dr. Slaoui also toured Temple’s vaccine trial site, met with a patient in the trial and took part in a press conference to wrap up his visit. Tony S. Reed, MD, MBA, Executive Vice President and Chief Medical Officer of Temple University Health System (TUHS) and Nina Gentile, MD, Professor of Emergency Medicine and Research Director in the Department of Emergency Medicine at the Lewis Katz School of Medicine at Temple University (LKSOM), and Temple’s principal investigator for the ENSEMBLE trial, also participated in the press conference. Multiple media outlets, including USA Today, covered the event. Yahoo! News and MSN.com picked up the USA Today article.
- Dr. Reed offered insight to the Philadelphia Inquirer about performing elective procedures during the COVID-19 pandemic, following a Pennsylvania Department of Health order requiring hospitals to reduce the number of elective procedures if two out of three criteria are met. The order covers hospitals by region.
- Maura Sammon, MD, Assistant Professor of Clinical Emergency Medicine at the Lewis Katz School of Medicine at Temple University, and Mari Siegel, MD, a palliative care physician at Temple University Hospital, spoke with the Philadelphia Inquirer about the continued importance of forgoing holiday gatherings, wearing masks and social distancing as coronavirus cases rise.
- Delana Wardlaw, MD, who practices at Temple Physicians, Inc. at Nicetown, was featured in a 6ABC segment about coronavirus vaccines.
- A Philadelphia Inquirer article included Temple University Health System’s focus on educating about the coronavirus vaccines.